List of SBIR/STTR awards granted to ImmPORT Therapeutics Inc dba Antigen Discovery Inc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in April, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI145607-01A1 | Phase I | 300,000 | April 1, 2020 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in May, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI157561-01A1 | Phase I | 300,000 | May 12, 2021 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in January, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI149804-01 | Phase I | 300,000 | January 1, 2020 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in March, 2018 for $224,852.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI138827-01 | Phase I | 224,852 | March 22, 2018 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in September, 2021 for $243,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001168-01A1 | Phase I | 243,000 | September 30, 2021 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in August, 2018 for $225,707.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136196-01 | Phase I | 225,707 | August 16, 2018 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in January, 2018 for $595,243.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136197-01 | Phase I | 595,243 | January 16, 2018 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $150,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 75D30118PO2540 | Phase I | 150,000 | ||||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in August, 2015 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DE025440-01 | Phase I | 225,000 | August 20, 2015 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in August, 2016 for $224,911.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124911-01 | Phase I | 224,911 | August 1, 2016 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc in February, 2017 for $224,958.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI132078-01 | Phase I | 224,958 | February 6, 2017 | |||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $598,668.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI066791-01 | Phase I | 598,668 | ||||||||
A STTR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $300,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI072847-01 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $886,845.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI063728-01A1 | Phase I | 886,845 | ||||||||
A SBIR Phase II contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $2,991,860.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI058365-03 | Phase II | 2,991,860 | ||||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $594,009.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI075692-01A1 | Phase I | 594,009 | ||||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $995,030.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI058365-01 | Phase I | 995,030 | ||||||||
A SBIR Phase II contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $2,341,413.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI066791-03 | Phase II | 2,341,413 | ||||||||
A STTR Phase II contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $1,847,310.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AI072847-03A1 | Phase II | 1,847,310 | ||||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI102288-01 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DE025165-01 | Phase I | 225,000 | ||||||||
A SBIR Phase I contract was awarded to ImmPORT Therapeutics Inc dba Antigen Discovery Inc for $525,836.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI072872-01A1 | Phase I | 525,836 |
